Literature DB >> 12454127

Laboratory assays for diagnosis and management of hepatitis C virus infection.

Sandra S Richter1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12454127      PMCID： PMC154655          DOI： 10.1128/JCM.40.12.4407-4412.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  41 in total

Review 1.  Hepatitis C virus infection.

Authors:  G M Lauer; B D Walker
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

2.  Hepatitis C virus genotyping based on 5' noncoding sequence analysis (Trugene).

Authors:  P Halfon; P Trimoulet; M Bourliere; H Khiri; V de Lédinghen; P Couzigou; J M Feryn; P Alcaraz; C Renou; H J Fleury; D Ouzan
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Performance of the New Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: conversion to international units and comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0, assay.

Authors:  Marcel Beld; Roel Sentjens; Sjoerd Rebers; Christine Weegink; Jan Weel; Cees Sol; René Boom
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

4.  Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2a.

Authors:  C Sarrazin; D A Hendricks; F Sedarati; S Zeuzem
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

5.  Performance characteristics of a transcription-mediated nucleic acid amplification assay for qualitative detection of hepatitis C virus RNA.

Authors:  R S Ross; S O Viazov; S Hoffmann; M Roggendorf
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

6.  Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics.

Authors:  S C Lee; A Antony; N Lee; J Leibow; J Q Yang; S Soviero; K Gutekunst; M Rosenstraus
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

7.  Standardization of hepatitis C virus RNA quantification.

Authors:  J M Pawlotsky; M Bouvier-Alias; C Hezode; F Darthuy; J Remire; D Dhumeaux
Journal:  Hepatology       Date:  2000-09       Impact factor: 17.425

8.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

9.  Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy.

Authors:  J G McHutchison; J A Shad; S C Gordon; T R Morgan; M H Ling; J J Garaud; J K Albrecht; J L Dienstag
Journal:  J Viral Hepat       Date:  2001-11       Impact factor: 3.728

10.  Comparative evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR version 2.0 Assays for quantification of hepatitis C virus RNA in serum.

Authors:  Jeffrey J Germer; Paul J Heimgartner; Duane M Ilstrup; W Scott Harmsen; Greg D Jenkins; Robin Patel
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948
View more
  32 in total

1.  Comparative evaluation of three commercially available methodologies for hepatitis C virus genotyping.

Authors:  Ted E Schutzbank; Susan E Sefers; Nicole Kahmann; Haijing Li; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

2.  Usefulness of the hepatitis C virus core antigen assay for screening of a population undergoing routine medical checkup.

Authors:  Catherine Gaudy; Catherine Thevenas; Jean Tichet; Nicole Mariotte; Alain Goudeau; Frédéric Dubois
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

3.  Comparison of a newly developed automated and quantitative hepatitis C virus (HCV) core antigen test with the HCV RNA assay for clinical usefulness in confirming anti-HCV results.

Authors:  Recep Kesli; Hakki Polat; Yuksel Terzi; Muhammet Guzel Kurtoglu; Yavuz Uyar
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

4.  Accuracy of rapid oral HCV diagnostic test among a Saudi sample.

Authors:  Suzan Ibrahim; Safia Ali Al Attas; Ghada Anwar Mansour; Soliman Ouda; Hind Fallatah
Journal:  Clin Oral Investig       Date:  2014-05-21       Impact factor: 3.573

5.  New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification.

Authors:  Yongjung Park; Jong-Han Lee; Beom Seok Kim; Do Young Kim; Kwang-Hyub Han; Hyon-Suk Kim
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

6.  High-resolution melting combines with Bayes discriminant analysis: a novel hepatitis C virus genotyping method.

Authors:  Daxian Wu; Xiaoyu Fu; Ya Wen; Bingjie Liu; Zhongping Deng; Lizhong Dai; Deming Tan
Journal:  Clin Exp Med       Date:  2016-05-13       Impact factor: 3.984

7.  Is hepatitis C virus core antigen an adequate marker for community screening?

Authors:  Yuan-Hung Kuo; Kuo-Chin Chang; Jing-Houng Wang; Pei-Shan Tsai; Shu-Feng Hung; Chao-Hung Hung; Chien-Hung Chen; Sheng-Nan Lu
Journal:  J Clin Microbiol       Date:  2012-03-29       Impact factor: 5.948

8.  The laboratory diagnosis of hepatitis B virus.

Authors:  Mel Krajden; Gail McNabb; Martin Petric
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-03       Impact factor: 2.471

9.  Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg, antibodies to HBsAg, and antibodies to hepatitis C virus.

Authors:  Nahed Ismail; Geoffrey E Fish; Michael B Smith
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

10.  Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0.

Authors:  Jannick Verbeeck; Mark J Stanley; Jen Shieh; Linda Celis; Els Huyck; Elke Wollants; Judy Morimoto; Alice Farrior; Erwin Sablon; Margaret Jankowski-Hennig; Carl Schaper; Pamela Johnson; Marc Van Ranst; Marianne Van Brussel
Journal:  J Clin Microbiol       Date:  2008-04-09       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.